---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-22-004180"
form_type: "8-K"
ticker: "XBIO"
cik: "0001534525"
company_name: "Xenetic Biosciences, Inc."
filed_at: "2022-06-06T23:59:59+00:00"
generated_at: "2026-06-25T04:19:08.471549+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Xenetic Biosciences receives Nasdaq minimum bid price deficiency notice

## Summary
- Nasdaq notified Xenetic on June 3, 2022 that its common stock bid price was below $1.00 for 30 consecutive business days.
- Company has 180 calendar days (until November 30, 2022) to regain compliance with Nasdaq Listing Rule 5550(a)(2).
- To cure, closing bid price must be at least $1.00 for a minimum of ten consecutive business days before the Compliance Date.
- If not cured by Nov 30, Xenetic may be eligible for a second 180-day period if it meets other listing standards and notifies Nasdaq of intention to cure, possibly via reverse stock split.
- There is no assurance the company will regain compliance; risk of delisting if deficiency is not addressed.

## SEC filing metadata
- accession: 0001683168-22-004180
- form_type: 8-K
- ticker: XBIO
- cik: 0001534525
- company_name: Xenetic Biosciences, Inc.
- filed_at: 2022-06-06T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1534525/000168316822004180/0001683168-22-004180-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1534525/000168316822004180/xenetic_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-22-004180
- JSON: https://secwatch.observer/filing/0001683168-22-004180.json
- Plain text: https://secwatch.observer/filing/0001683168-22-004180.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.